Creek Drive Management Group LLC boosted its stake in Strata Critical Medical (NASDAQ:SRTA – Free Report) by 25.6% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 736,000 shares of the company’s stock after acquiring an additional 149,800 shares during the quarter. Strata Critical Medical accounts for about 1.0% of Creek Drive Management Group LLC’s portfolio, making the stock its 23rd biggest holding. Creek Drive Management Group LLC’s holdings in Strata Critical Medical were worth $3,761,000 as of its most recent filing with the SEC.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Landscape Capital Management L.L.C. increased its holdings in Strata Critical Medical by 71.4% in the 3rd quarter. Landscape Capital Management L.L.C. now owns 407,980 shares of the company’s stock worth $2,085,000 after acquiring an additional 169,948 shares in the last quarter. Royce & Associates LP raised its position in Strata Critical Medical by 0.5% during the third quarter. Royce & Associates LP now owns 3,147,490 shares of the company’s stock worth $16,084,000 after acquiring an additional 14,557 shares during the period. Virtus Advisers LLC purchased a new position in Strata Critical Medical during the third quarter valued at $196,000. Fisher Asset Management LLC purchased a new position in Strata Critical Medical during the third quarter valued at $56,000. Finally, Russell Investments Group Ltd. lifted its holdings in Strata Critical Medical by 5.2% during the third quarter. Russell Investments Group Ltd. now owns 452,054 shares of the company’s stock valued at $2,310,000 after purchasing an additional 22,381 shares in the last quarter. Hedge funds and other institutional investors own 47.36% of the company’s stock.
Wall Street Analyst Weigh In
Separately, Weiss Ratings reiterated a “hold (c-)” rating on shares of Strata Critical Medical in a research report on Tuesday, November 3rd. One research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $8.00.
Read Our Latest Stock Analysis on Strata Critical Medical
Strata Critical Medical Trading Down 5.3%
SRTA stock opened at $4.96 on Thursday. The firm has a 50-day moving average of $5.01 and a two-hundred day moving average of $5.23. Strata Critical Medical has a 12 month low of $3.95 and a 12 month high of $6.50. The company has a market cap of $443.03 million, a price-to-earnings ratio of -165.33 and a beta of 2.56.
Strata Critical Medical (NASDAQ:SRTA – Get Free Report) last issued its earnings results on Tuesday, November 3rd. The company reported ($0.09) earnings per share for the quarter, missing the consensus estimate of $0.01 by ($0.10). The company had revenue of $74.08 million for the quarter. Strata Critical Medical had a negative return on equity of 2.71% and a negative net margin of 8.84%. As a group, equities analysts forecast that Strata Critical Medical will post -0.12 earnings per share for the current year.
Strata Critical Medical Company Profile
Blade Air Mobility, Inc. provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.
Featured Stories
- Five stocks we like better than Strata Critical Medical
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
- Viking’s Low-Water Miss Looks Like a Buy-the-Dip Opportunity
- Why Amazon Wants the Chips and Blackstone Wants the Buildings
Want to see what other hedge funds are holding SRTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Strata Critical Medical (NASDAQ:SRTA – Free Report).
Receive News & Ratings for Strata Critical Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Strata Critical Medical and related companies with MarketBeat.com's FREE daily email newsletter.
